Ruby M. Van Stein - Publications

Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.

Journal: JCO oncology practice

Published: December 19, 2025

Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 04, 2025

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer.

Journal: Gynecologic oncology reports

Published: July 17, 2023

Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary?

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: December 23, 2022

Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: September 18, 2022

Future of HIPEC for ovarian cancer.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: June 16, 2022

Turning up the heat does not affect quality of life.

Journal: Journal of gynecologic oncology

Published: June 15, 2022

Peroperative extent of peritoneal metastases affects the surgical outcome and survival in advanced ovarian cancer.

Journal: Gynecologic oncology

Published: June 07, 2022

Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus.

Journal: Gynecologic oncology reports

Published: December 06, 2021

Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.

Journal: JAMA oncology

Published: May 06, 2021

Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 13, 2020

Effects of Sampling Conditions and Environmental Factors on Fecal Volatile Organic Compound Analysis by an Electronic Nose Device.

Journal: Sensors (Basel, Switzerland)

Published: August 06, 2016